DrugPatentWatch Database Preview
Sun Pharma Global Company Profile
» See Plans and Pricing
US Patents for Sun Pharma Global
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Global | ILUMYA | tildrakizumab-asmn | INJECTABLE;INJECTION | 761067 | 001 | 2018-03-20 | RX | |||||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
